MRNA 8-K: Material agreement

Moderna

Filed with the SEC on · accession 0001682852-26-000208

MRNA filed a 8-K (current report) with the SEC on Nov 16, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -3.6% by the first close after the filing.

Summary of the filing

Moderna entered into Amendment No. 1 to its Credit and Guaranty Agreement with Ares Capital Corporation, reducing interest rate margins by 0.75 percentage points and extending the loan maturity date by one year to November 24, 2031.

Key details

Initial term loans and delayed draw term loans interest rate margin reduction (SOFR-based)percentage points 1
First $400 million delayed draw term loan commitments availability extension$400.0M
Remaining $500 million delayed draw term loan commitments availability extension$500.0M
BorrowerModerna, Inc.
Administrative agent and collateral agentAres Capital Corporation
Chief financial officerJames M. Mock

How MRNA stock reacted

Close before

$223.37

Nov 13, 2026

First close after

-3.63%

$215.27

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for MRNA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MRNA?

Click here

Frequently asked questions

What did MRNA file with the SEC on Nov 16, 2026?

MRNA filed a 8-K (Material agreement). Moderna entered into Amendment No. 1 to its Credit and Guaranty Agreement with Ares Capital Corporation, reducing interest rate margins by 0.75 percentage points and extending the loan maturity date by one year to November 24, 2031.

What does a material agreement mean for MRNA stock?

A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did MRNA stock react to this filing?

MRNA closed at $223.37 before the filing and $215.27 on Nov 16, 2026 (-3.63%).

Other MRNA SEC filings

Get alerts when MRNA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days